TY - JOUR AU - Bax, M. AU - Goldstein, M. AU - Rosenbaum, P. PY - 2005 DA - 2005// TI - Proposed definition and classification of cerebral palsy, April 2005 JO - Dev Med Child Neurol VL - 47 UR - https://doi.org/10.1017/S001216220500112X DO - 10.1017/S001216220500112X ID - Bax2005 ER - TY - JOUR AU - Oskoui, M. AU - Coutinho, F. AU - Dykeman, J. AU - Jetté, N. AU - Pringsheim, T. PY - 2013 DA - 2013// TI - An update on the prevalence of cerebral palsy: a systematic review and meta-analysis JO - Dev Med Child Neurol VL - 55 UR - https://doi.org/10.1111/dmcn.12080 DO - 10.1111/dmcn.12080 ID - Oskoui2013 ER - TY - JOUR AU - Pavone, V. AU - Testa, G. AU - Restivo, D. A. AU - Cannavò, L. AU - Condorelli, G. AU - Portinaro, N. M. AU - Sessa, G. PY - 2016 DA - 2016// TI - Botulinum toxin treatment for limb spasticity in childhood cerebral palsy JO - Front Pharmacol VL - 7 UR - https://doi.org/10.3389/fphar.2016.00029 DO - 10.3389/fphar.2016.00029 ID - Pavone2016 ER - TY - JOUR AU - Krigger, K. W. PY - 2006 DA - 2006// TI - Cerebral palsy: an overview JO - Am Fam Physician VL - 73 ID - Krigger2006 ER - TY - JOUR AU - Morrell, D. S. AU - Pearson, J. M. AU - Sauser, D. D. PY - 2002 DA - 2002// TI - Progressive bone and joint abnormalities of the spine and lower extremities in cerebral palsy JO - Radiographics VL - 22 UR - https://doi.org/10.1148/radiographics.22.2.g02mr19257 DO - 10.1148/radiographics.22.2.g02mr19257 ID - Morrell2002 ER - TY - JOUR AU - Pandyan, A. D. AU - Gregoric, M. AU - Barnes, M. P. AU - Wood, D. AU - Wijck, F. AU - Burridge, J. AU - Hermens, H. AU - Johnson, G. R. PY - 2005 DA - 2005// TI - Spasticity: clinical perceptions, neurological realities and meaningful measurement JO - Disabil Rehabil VL - 27 UR - https://doi.org/10.1080/09638280400014576 DO - 10.1080/09638280400014576 ID - Pandyan2005 ER - TY - JOUR AU - Heinen, F. AU - Desloovere, K. AU - Schroeder, A. S. AU - Berweck, S. AU - Borggraefe, I. AU - Campenhout, A. AU - Andersen, G. L. AU - Aydin, R. AU - Becher, J. G. AU - Bernert, G. PY - 2010 DA - 2010// TI - The updated European consensus 2009 on the use of Botulinum toxin for children with cerebral palsy JO - Eur J Paediatr Neurol VL - 14 UR - https://doi.org/10.1016/j.ejpn.2009.09.005 DO - 10.1016/j.ejpn.2009.09.005 ID - Heinen2010 ER - TY - JOUR AU - Strobl, W. AU - Theologis, T. AU - Brunner, R. AU - Kocer, S. AU - Viehweger, E. AU - Pascual-Pascual, I. AU - Placzek, R. PY - 2015 DA - 2015// TI - Best clinical practice in botulinum toxin treatment for children with cerebral palsy JO - Toxins (Basel) VL - 7 UR - https://doi.org/10.3390/toxins7051629 DO - 10.3390/toxins7051629 ID - Strobl2015 ER - TY - JOUR AU - Love, S. C. AU - Novak, I. AU - Kentish, M. AU - Desloovere, K. AU - Heinen, F. AU - Molenaers, G. AU - O'Flaherty, S. AU - Graham, H. K. PY - 2010 DA - 2010// TI - Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement JO - Eur J Neurol VL - 17 UR - https://doi.org/10.1111/j.1468-1331.2010.03126.x DO - 10.1111/j.1468-1331.2010.03126.x ID - Love2010 ER - TY - JOUR AU - Dressler, D. AU - Adib, S. F. PY - 2005 DA - 2005// TI - Botulinum toxin: mechanisms of action JO - Eur Neurol VL - 53 UR - https://doi.org/10.1159/000083259 DO - 10.1159/000083259 ID - Dressler2005 ER - TY - JOUR AU - Wissel, J. AU - Müller, J. AU - Dressnandt, J. AU - Heinen, F. AU - Naumann, M. AU - Topka, H. AU - Poewe, W. PY - 2000 DA - 2000// TI - Management of spasticity associated pain with botulinum toxin a JO - J Pain Symptom Manag VL - 20 UR - https://doi.org/10.1016/S0885-3924(00)00146-9 DO - 10.1016/S0885-3924(00)00146-9 ID - Wissel2000 ER - TY - JOUR AU - Dressler, D. PY - 2012 DA - 2012// TI - Five-year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins JO - Eur J Neurol VL - 19 UR - https://doi.org/10.1111/j.1468-1331.2011.03559.x DO - 10.1111/j.1468-1331.2011.03559.x ID - Dressler2012 ER - TY - JOUR AU - Frevert, J. PY - 2010 DA - 2010// TI - Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture® JO - Drugs R D VL - 10 UR - https://doi.org/10.2165/11584780-000000000-00000 DO - 10.2165/11584780-000000000-00000 ID - Frevert2010 ER - TY - JOUR AU - Barnes, M. AU - Schnitzler, A. AU - Medeiros, L. AU - Aguilar, M. AU - Lehnert-Batar, A. AU - Minnasch, P. PY - 2010 DA - 2010// TI - Efficacy and safety of NT 201 for upper limb spasticity of various etiologies – a randomized parallel-group study JO - Acta Neurol Scand VL - 122 UR - https://doi.org/10.1111/j.1600-0404.2010.01354.x DO - 10.1111/j.1600-0404.2010.01354.x ID - Barnes2010 ER - TY - JOUR AU - Elovic, E. P. AU - Munin, M. C. AU - Kaňovský, P. AU - Hanschmann, A. AU - Hiersemenzel, R. AU - Marciniak, C. PY - 2016 DA - 2016// TI - Randomized, placebo-controlled trial of incobotulinumtoxinA for upper-limb post-stroke spasticity JO - Muscle Nerve VL - 53 UR - https://doi.org/10.1002/mus.24776 DO - 10.1002/mus.24776 ID - Elovic2016 ER - TY - JOUR AU - Kaňovský, P. AU - Slawek, J. AU - Denes, Z. AU - Platz, T. AU - Sassin, I. AU - Comes, G. AU - Grafe, S. PY - 2009 DA - 2009// TI - Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity JO - Clin Neuropharmacol VL - 32 UR - https://doi.org/10.1097/WNF.0b013e3181b13308 DO - 10.1097/WNF.0b013e3181b13308 ID - Kaňovský2009 ER - TY - JOUR AU - Kaňovský, P. AU - Slawek, J. AU - Denes, Z. AU - Platz, T. AU - Comes, G. AU - Grafe, S. AU - Pulte, I. PY - 2011 DA - 2011// TI - Efficacy and safety of treatment with incobotulinum toxin a (botulinum neurotoxin type a free from complexing proteins; NT 201) in post-stroke upper limb spasticity JO - J Rehabil Med VL - 43 UR - https://doi.org/10.2340/16501977-0796 DO - 10.2340/16501977-0796 ID - Kaňovský2011 ER - TY - JOUR AU - Carraro, E. AU - Trevisi, E. AU - Martinuzzi, A. PY - 2016 DA - 2016// TI - Safety profile of incobotulinum toxin a [Xeomin®] in gastrocnemious muscles injections in children with cerebral palsy: randomized double-blind clinical trial JO - Eur J Paediatr Neurol VL - 20 UR - https://doi.org/10.1016/j.ejpn.2016.04.008 DO - 10.1016/j.ejpn.2016.04.008 ID - Carraro2016 ER - TY - JOUR AU - Palisano, R. AU - Rosenbaum, P. AU - Walter, S. AU - Russell, D. AU - Wood, E. AU - Galuppi, B. PY - 1997 DA - 1997// TI - Development and reliability of a system to classify gross motor function in children with cerebral palsy JO - Dev Med Child Neurol VL - 39 UR - https://doi.org/10.1111/j.1469-8749.1997.tb07414.x DO - 10.1111/j.1469-8749.1997.tb07414.x ID - Palisano1997 ER - TY - JOUR AU - Eliasson, A. C. AU - Krumlinde-Sundholm, L. AU - Rösblad, B. AU - Beckung, E. AU - Arner, M. AU - Ohrvall, A. M. AU - Rosenbaum, P. PY - 2006 DA - 2006// TI - The manual ability classification system (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability JO - Dev Med Child Neurol VL - 48 UR - https://doi.org/10.1017/S0012162206001162 DO - 10.1017/S0012162206001162 ID - Eliasson2006 ER - TY - JOUR AU - Blumetti, F. C. AU - Belloti, J. C. AU - Tamaoki, M. J. S. AU - Pinto, J. A. PY - 2019 DA - 2019// TI - Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy JO - Cochrane Database Syst Rev VL - 10 UR - https://doi.org/10.1002/14651858.CD001408.pub2 DO - 10.1002/14651858.CD001408.pub2 ID - Blumetti2019 ER - TY - JOUR AU - Kerr, G. PY - 2008 DA - 2008// TI - Safety of botulinum toxin a in cerebral palsy JO - Toxicon VL - 51 UR - https://doi.org/10.1016/j.toxicon.2008.04.085 DO - 10.1016/j.toxicon.2008.04.085 ID - Kerr2008 ER - TY - JOUR AU - Naidu, K. AU - Smith, K. AU - Sheedy, M. AU - Adair, B. AU - Yu, X. AU - Graham, H. K. PY - 2010 DA - 2010// TI - Systemic adverse events following botulinum toxin a therapy in children with cerebral palsy JO - Dev Med Child Neurol VL - 52 UR - https://doi.org/10.1111/j.1469-8749.2009.03583.x DO - 10.1111/j.1469-8749.2009.03583.x ID - Naidu2010 ER -